Assenagon Asset Management’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.7M Buy
1,252,027
+524,041
+72% +$13.3M 0.04% 306
2026
Q1
$18.2M Buy
727,986
+80,612
+12% +$1.91M 0.03% 349
2025
Q4
$17M Sell
647,374
-679,400
-51% -$14.8M 0.02% 392
2025
Q3
$22.7M Buy
1,326,774
+833,994
+169% +$11.9M 0.03% 344
2025
Q2
$6.18M Sell
492,780
-2,287
-0.5% -$27.2K 0.01% 534
2025
Q1
$5.9M Sell
495,067
-147,184
-23% -$2.01M 0.01% 513
2024
Q4
$9.4M Buy
642,251
+311,107
+94% +$4.35M 0.02% 531
2024
Q3
$4.16M Buy
+331,144
New +$3.61M 0.01% 761
2024
Q2
Sell
-166,549
Closed -$1.75M 1509
2024
Q1
$1.75M Buy
+166,549
New +$1.85M ﹤0.01% 931

Other funds holding ZYME

Assenagon Asset Management's ZYME Position: Q2 2026 in Review

Assenagon Asset Management increased its Zymeworks (ZYME) stake by 72% in Q2 2026, buying an estimated $13.3M and bringing the position to 1,252,027 shares worth $32.7M. The position accounts for 0.04% of the portfolio, ranked #306.

Assenagon Asset Management first reported a position in ZYME in Q1 2024 and has held it in 9 quarters since. 36 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Assenagon Asset Management held 1,252,027 shares of Zymeworks worth $32.7M as of Q2 2026.
  • Assenagon Asset Management bought 524,041 Zymeworks shares in Q2 2026, an estimated $13.3M.
  • Zymeworks made up 0.04% of Assenagon Asset Management's portfolio in Q2 2026, its #306 holding.
  • Assenagon Asset Management first reported a position in Zymeworks in Q1 2024 and has held it in 9 quarters since.
  • 36 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.